Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
38
XRAY Quote, Financials, Valuation and Earnings
Last price:
$15.79
Seasonality move
:
1.01%
Day range:
$15.56 - $16.03
52-week range:
$12.16 - $27.95
Dividend yield:
4.05%
P/E ratio:
--
P/S ratio:
0.86x
P/B ratio:
1.57x
Volume:
1.7M
Avg. volume:
2.1M
1-year change:
-41.03%
Market cap:
$3.2B
Revenue:
$3.8B
EPS (TTM):
-$4.54
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.3B | $4.2B | $3.9B | $4B | $3.8B | |
| Revenue Growth (YoY) | -16.98% | 26.72% | -7.3% | 1.1% | -4.34% | |
| Cost of Revenues | $1.7B | $1.9B | $1.8B | $1.9B | $1.8B | |
| Gross Profit | $1.7B | $2.3B | $2.1B | $2.1B | $2B | |
| Gross Profit Margin | 49.6% | 55.47% | 54.23% | 52.61% | 51.62% | |
| R&D Expenses | $123M | $171M | $174M | $184M | $165M | |
| Selling, General & Admin | $1.3B | $1.6B | $1.6B | $1.6B | $1.6B | |
| Other Inc / (Exp) | -$235M | -$19M | -$1.4B | -$383M | -$1.1B | |
| Operating Expenses | $1.4B | $1.7B | $1.8B | $1.8B | $1.8B | |
| Operating Income | $231M | $625M | $364M | $289M | $188M | |
| Net Interest Expenses | $46M | $61M | $65M | $81M | $69M | |
| EBT. Incl. Unusual Items | -$50M | $545M | -$1.1B | -$175M | -$936M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $23M | $134M | -$105M | -$43M | -$26M | |
| Net Income to Company | -$73M | $411M | -$950M | -$132M | -$910M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$73M | $411M | -$950M | -$132M | -$910M | |
| Basic EPS (Cont. Ops) | -$0.33 | $1.88 | -$4.41 | -$0.62 | -$4.48 | |
| Diluted EPS (Cont. Ops) | -$0.33 | $1.87 | -$4.41 | -$0.62 | -$4.48 | |
| Weighted Average Basic Share | $219.2M | $218.4M | $215.5M | $212M | $203.2M | |
| Weighted Average Diluted Share | $219.2M | $220.2M | $215.5M | $212M | $203.2M | |
| EBITDA | $330M | $952M | -$662M | $249M | -$518M | |
| EBIT | -$4M | $606M | -$990M | -$94M | -$867M | |
| Revenue (Reported) | $3.3B | $4.2B | $3.9B | $4B | $3.8B | |
| Operating Income (Reported) | $231M | $625M | $364M | $289M | $188M | |
| Operating Income (Adjusted) | -$4M | $606M | -$990M | -$94M | -$867M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | $969M | $978M | $953M | $879M | |
| Revenue Growth (YoY) | 17.39% | -5.56% | 0.93% | -2.56% | -7.77% | |
| Cost of Revenues | $447M | $448M | $459M | $447M | $413M | |
| Gross Profit | $579M | $521M | $519M | $506M | $466M | |
| Gross Profit Margin | 56.43% | 53.77% | 53.07% | 53.1% | 53.02% | |
| R&D Expenses | $40M | $45M | $46M | $42M | $36M | |
| Selling, General & Admin | $386M | $378M | $418M | $417M | $360M | |
| Other Inc / (Exp) | $6M | $1M | -$63M | $2M | -$7M | |
| Operating Expenses | $426M | $423M | $464M | $459M | $396M | |
| Operating Income | $153M | $98M | $55M | $47M | $70M | |
| Net Interest Expenses | $14M | $12M | $20M | $18M | $19M | |
| EBT. Incl. Unusual Items | $145M | $87M | -$28M | $31M | $44M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $33M | $18M | -$5M | $14M | $25M | |
| Net Income to Company | $112M | $69M | -$23M | $17M | $19M | |
| Minority Interest in Earnings | -- | -- | $4M | $1M | $1M | |
| Net Income to Common Excl Extra Items | $112M | $69M | -$19M | $18M | $20M | |
| Basic EPS (Cont. Ops) | $0.51 | $0.32 | -$0.09 | $0.09 | $0.10 | |
| Diluted EPS (Cont. Ops) | $0.51 | $0.32 | -$0.09 | $0.09 | $0.10 | |
| Weighted Average Basic Share | $218.8M | $217M | $214.5M | $207.4M | $199.1M | |
| Weighted Average Diluted Share | $219.9M | $217.8M | $214.5M | $208.5M | $199.8M | |
| EBITDA | $247M | $183M | $76M | $135M | $142M | |
| EBIT | $159M | $99M | -$8M | $49M | $63M | |
| Revenue (Reported) | $1B | $969M | $978M | $953M | $879M | |
| Operating Income (Reported) | $153M | $98M | $55M | $47M | $70M | |
| Operating Income (Adjusted) | $159M | $99M | -$8M | $49M | $63M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.5B | $4.2B | $3.9B | $3.9B | $3.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.7B | $1.9B | $1.8B | $1.9B | $1.8B | |
| Gross Profit | $1.8B | $2.3B | $2.1B | $2.1B | $1.9B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $125M | $176M | $175M | $180M | $159M | |
| Selling, General & Admin | $1.3B | $1.5B | $1.6B | $1.6B | $1.5B | |
| Other Inc / (Exp) | -$31M | -$27M | -$1.4B | -$318M | -$1.1B | |
| Operating Expenses | $1.5B | $1.7B | $1.8B | $1.8B | $1.7B | |
| Operating Income | $296M | $573M | $321M | $281M | $212M | |
| Net Interest Expenses | $54M | $59M | $73M | $79M | $70M | |
| EBT. Incl. Unusual Items | $211M | $487M | -$1.2B | -$116M | -$923M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $42M | $119M | -$128M | -$24M | -$15M | |
| Net Income to Company | $179M | $368M | -$1B | -$92M | -$908M | |
| Minority Interest in Earnings | -- | -- | $4M | -$3M | -- | |
| Net Income to Common Excl Extra Items | $169M | $368M | -$1B | -$95M | -$908M | |
| Basic EPS (Cont. Ops) | $0.74 | $1.62 | -$4.83 | -$0.43 | -$4.54 | |
| Diluted EPS (Cont. Ops) | $0.74 | $1.60 | -$4.83 | -$0.44 | -$4.54 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $608M | $888M | -$769M | $308M | -$511M | |
| EBIT | $265M | $546M | -$1.1B | -$37M | -$853M | |
| Revenue (Reported) | $3.5B | $4.2B | $3.9B | $3.9B | $3.7B | |
| Operating Income (Reported) | $296M | $573M | $321M | $281M | $212M | |
| Operating Income (Adjusted) | $265M | $546M | -$1.1B | -$37M | -$853M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | $969M | $978M | $953M | $879M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $447M | $448M | $459M | $447M | $413M | |
| Gross Profit | $579M | $521M | $519M | $506M | $466M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $40M | $45M | $46M | $42M | $36M | |
| Selling, General & Admin | $386M | $378M | $418M | $417M | $360M | |
| Other Inc / (Exp) | $6M | $1M | -$63M | $2M | -$7M | |
| Operating Expenses | $426M | $423M | $464M | $459M | $396M | |
| Operating Income | $153M | $98M | $55M | $47M | $70M | |
| Net Interest Expenses | $14M | $12M | $20M | $18M | $19M | |
| EBT. Incl. Unusual Items | $145M | $87M | -$28M | $31M | $44M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $33M | $18M | -$5M | $14M | $25M | |
| Net Income to Company | $112M | $69M | -$23M | $17M | $19M | |
| Minority Interest in Earnings | -- | -- | $4M | $1M | $1M | |
| Net Income to Common Excl Extra Items | $112M | $69M | -$19M | $18M | $20M | |
| Basic EPS (Cont. Ops) | $0.51 | $0.32 | -$0.09 | $0.09 | $0.10 | |
| Diluted EPS (Cont. Ops) | $0.51 | $0.32 | -$0.09 | $0.09 | $0.10 | |
| Weighted Average Basic Share | $218.8M | $217M | $214.5M | $207.4M | $199.1M | |
| Weighted Average Diluted Share | $219.9M | $217.8M | $214.5M | $208.5M | $199.8M | |
| EBITDA | $247M | $183M | $76M | $135M | $142M | |
| EBIT | $159M | $99M | -$8M | $49M | $63M | |
| Revenue (Reported) | $1B | $969M | $978M | $953M | $879M | |
| Operating Income (Reported) | $153M | $98M | $55M | $47M | $70M | |
| Operating Income (Adjusted) | $159M | $99M | -$8M | $49M | $63M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $438M | $339M | $365M | $334M | $272M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $667M | $750M | $632M | $695M | $556M | |
| Inventory | $476M | $515M | $627M | $624M | $564M | |
| Prepaid Expenses | $111M | $111M | $128M | $146M | $151M | |
| Other Current Assets | $67M | $84M | $88M | $113M | $153M | |
| Total Current Assets | $1.8B | $1.9B | $1.9B | $2B | $1.7B | |
| Property Plant And Equipment | $967M | $971M | $961M | $978M | $902M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $4B | $4B | $2.7B | $2.4B | $1.6B | |
| Other Intangibles | $2.5B | $2.3B | $1.9B | $1.7B | $1.2B | |
| Other Long-Term Assets | $95M | $121M | $198M | $276M | $301M | |
| Total Assets | $9.4B | $9.2B | $7.6B | $7.4B | $5.8B | |
| Accounts Payable | $302M | $262M | $279M | $305M | $241M | |
| Accrued Expenses | $432M | $424M | $401M | $427M | $480M | |
| Current Portion Of Long-Term Debt | $299M | $12M | $23M | $97M | $139M | |
| Current Portion Of Capital Lease Obligations | $48M | $50M | $54M | $56M | $46M | |
| Other Current Liabilities | $32M | $3M | $19M | $18M | $12M | |
| Total Current Liabilities | $1.4B | $1.3B | $1.2B | $1.4B | $1.6B | |
| Long-Term Debt | $2B | $1.9B | $1.8B | $1.8B | $1.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.4B | $4.2B | $3.8B | $4.1B | $3.8B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | |
| Other Common Equity Adj | -$464M | -$592M | -$628M | -$636M | -$730M | |
| Common Equity | $4.9B | $5B | $3.8B | $3.3B | $1.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $3M | $1M | $1M | $1M | $1M | |
| Total Equity | $4.9B | $5B | $3.8B | $3.3B | $1.9B | |
| Total Liabilities and Equity | $9.4B | $9.2B | $7.6B | $7.4B | $5.8B | |
| Cash and Short Terms | $438M | $339M | $365M | $334M | $272M | |
| Total Debt | $2.3B | $2.1B | $1.9B | $2.1B | $2.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $318M | $374M | $318M | $291M | $398M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $643M | $707M | $652M | $656M | $604M | |
| Inventory | $500M | $553M | $659M | $613M | $612M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $235M | $263M | $314M | $342M | $364M | |
| Total Current Assets | $1.7B | $1.9B | $1.9B | $1.9B | $2B | |
| Property Plant And Equipment | $926M | $975M | $961M | $953M | $924M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $4B | $3.9B | $2.7B | $2.4B | $1.6B | |
| Other Intangibles | $2.5B | $2.2B | $1.9B | $1.6B | $1.2B | |
| Other Long-Term Assets | $102M | $128M | $206M | $250M | $304M | |
| Total Assets | $9.1B | $9.2B | $7.7B | $7.1B | $6.1B | |
| Accounts Payable | $283M | $277M | $267M | $279M | $276M | |
| Accrued Expenses | $557M | $694M | $748M | $681M | $738M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.2B | $1.4B | $1.4B | $1.3B | $1.8B | |
| Long-Term Debt | $1.9B | $1.9B | $1.8B | $1.7B | $1.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.2B | $4.3B | $4B | $3.9B | $4B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | |
| Other Common Equity Adj | -$554M | -$629M | -$614M | -$666M | -$659M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $3M | $1M | -$3M | -- | -- | |
| Total Equity | $4.9B | $4.9B | $3.6B | $3.3B | $2B | |
| Total Liabilities and Equity | $9.1B | $9.2B | $7.7B | $7.1B | $6.1B | |
| Cash and Short Terms | $318M | $374M | $318M | $291M | $398M | |
| Total Debt | $2.3B | $2.2B | $2.2B | $2.1B | $2.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$73M | $411M | -$950M | -$132M | -$910M | |
| Depreciation & Amoritzation | $334M | $346M | $328M | $343M | $349M | |
| Stock-Based Compensation | $47M | $48M | $59M | $46M | $39M | |
| Change in Accounts Receivable | $131M | -$117M | $85M | -$58M | $104M | |
| Change in Inventories | $123M | -$64M | -$141M | $6M | $17M | |
| Cash From Operations | $649M | $657M | $517M | $377M | $461M | |
| Capital Expenditures | $87M | $142M | $149M | $149M | $180M | |
| Cash Acquisitions | -$1.1B | -$220M | -- | $13M | -- | |
| Cash From Investing | -$1.1B | -$358M | -$138M | -$89M | -$197M | |
| Dividends Paid (Ex Special Dividend) | -- | -$92M | -$104M | -$116M | -$126M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.5B | $16M | $6M | -- | $1M | |
| Long-Term Debt Repaid | -$701M | -$297M | -$2M | -$7M | -$88M | |
| Repurchase of Common Stock | -$228M | -$200M | -$150M | -$300M | -$250M | |
| Other Financing Activities | -$56M | -$36M | -$15M | -$10M | -$16M | |
| Cash From Financing | $476M | -$379M | -$329M | -$307M | -$302M | |
| Beginning Cash (CF) | $405M | $438M | $339M | $365M | $334M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $19M | -$80M | $50M | -$19M | -$38M | |
| Ending Cash (CF) | $438M | $339M | $365M | $334M | $272M | |
| Levered Free Cash Flow | $562M | $515M | $368M | $228M | $281M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $112M | $69M | -$23M | $17M | $19M | |
| Depreciation & Amoritzation | $88M | $84M | $84M | $86M | $79M | |
| Stock-Based Compensation | $13M | $11M | $17M | $11M | $10M | |
| Change in Accounts Receivable | $13M | $34M | -$15M | $27M | -$31M | |
| Change in Inventories | -$51M | -$41M | -$30M | -$5M | -$26M | |
| Cash From Operations | $49M | $93M | -$21M | $25M | $7M | |
| Capital Expenditures | $30M | $44M | $39M | $34M | $19M | |
| Cash Acquisitions | -$73M | -- | -- | -- | -- | |
| Cash From Investing | -$103M | -$43M | -$37M | -$43M | -$17M | |
| Dividends Paid (Ex Special Dividend) | -$22M | -$24M | -$27M | -$29M | -$32M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $34M | $168M | $198M | $23M | $435M | |
| Long-Term Debt Repaid | -- | -$2M | -- | -$3M | -$274M | |
| Repurchase of Common Stock | -$90M | -$150M | -$150M | -- | -- | |
| Other Financing Activities | -$8M | -$7M | -$4M | -$5M | -$6M | |
| Cash From Financing | -$53M | -$10M | $17M | -$14M | $123M | |
| Beginning Cash (CF) | $438M | $339M | $365M | $334M | $272M | |
| Foreign Exchange Rate Adjustment | -$13M | -$5M | -$6M | -$11M | $13M | |
| Additions / Reductions | -$107M | $40M | -$41M | -$32M | $113M | |
| Ending Cash (CF) | $318M | $374M | $318M | $291M | $398M | |
| Levered Free Cash Flow | $19M | $49M | -$60M | -$9M | -$12M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $179M | $368M | -$1B | -$92M | -$908M | |
| Depreciation & Amoritzation | $343M | $342M | $328M | $345M | $342M | |
| Stock-Based Compensation | $50M | $46M | $65M | $40M | $38M | |
| Change in Accounts Receivable | $91M | -$96M | $36M | -$16M | $46M | |
| Change in Inventories | $129M | -$54M | -$130M | $31M | -$4M | |
| Cash From Operations | $708M | $701M | $403M | $423M | $443M | |
| Capital Expenditures | $91M | $156M | $144M | $144M | $165M | |
| Cash Acquisitions | -$1.2B | -$147M | -- | -- | -- | |
| Cash From Investing | -$1.2B | -$298M | -$132M | -$95M | -$171M | |
| Dividends Paid (Ex Special Dividend) | -- | -$94M | -$107M | -$118M | -$129M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.5B | $150M | $36M | -$175M | $413M | |
| Long-Term Debt Repaid | -$700M | -$299M | -- | -$10M | -$359M | |
| Repurchase of Common Stock | -$178M | -$260M | -$150M | -$150M | -- | |
| Other Financing Activities | -$62M | -$35M | -$12M | -$11M | -$17M | |
| Cash From Financing | $553M | -$336M | -$302M | -$338M | -$165M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $68M | $67M | -$31M | -$10M | $107M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $617M | $545M | $259M | $279M | $278M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $112M | $69M | -$23M | $17M | $19M | |
| Depreciation & Amoritzation | $88M | $84M | $84M | $86M | $79M | |
| Stock-Based Compensation | $13M | $11M | $17M | $11M | $10M | |
| Change in Accounts Receivable | $13M | $34M | -$15M | $27M | -$31M | |
| Change in Inventories | -$51M | -$41M | -$30M | -$5M | -$26M | |
| Cash From Operations | $49M | $93M | -$21M | $25M | $7M | |
| Capital Expenditures | $30M | $44M | $39M | $34M | $19M | |
| Cash Acquisitions | -$73M | -- | -- | -- | -- | |
| Cash From Investing | -$103M | -$43M | -$37M | -$43M | -$17M | |
| Dividends Paid (Ex Special Dividend) | -$22M | -$24M | -$27M | -$29M | -$32M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $34M | $168M | $198M | $23M | $435M | |
| Long-Term Debt Repaid | -- | -$2M | -- | -$3M | -$274M | |
| Repurchase of Common Stock | -$90M | -$150M | -$150M | -- | -- | |
| Other Financing Activities | -$8M | -$7M | -$4M | -$5M | -$6M | |
| Cash From Financing | -$53M | -$10M | $17M | -$14M | $123M | |
| Beginning Cash (CF) | $438M | $339M | $365M | $334M | $272M | |
| Foreign Exchange Rate Adjustment | -$13M | -$5M | -$6M | -$11M | $13M | |
| Additions / Reductions | -$107M | $40M | -$41M | -$32M | $113M | |
| Ending Cash (CF) | $318M | $374M | $318M | $291M | $398M | |
| Levered Free Cash Flow | $19M | $49M | -$60M | -$9M | -$12M | |
Get XRAY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
XRAY
Sector
P/E ratio
--
23.88x
PEG ratio
0.00x
0.00x
P/B ratio
1.57x
1.80x
Price / LTM sales
0.86x
1.65x
Growth Metrics
XRAY
Sector
Revenue growth
-7.77%
4.06%
Earnings growth
11.11%
7.46%
Revenue (5-year growth)
-1.17%
8.01%
Earnings forecast
$0.50
-$0.20
Profitability
XRAY
Sector
Profitability FY 2024
$2B
$47.5M
Return on invested capital
-19.2%
-16.26%
Return on assets
-13.99%
-13.27%
Return on equity
-35.57%
-18.61%
Earnings Date
Last Earnings Date
May
8
Next Earnings Date
Aug
7
Estimated Next Earnings Date
Aug
7
Balance Sheet
XRAY
Sector
Total cash
$398M
$35.5M
Short term investments
--
$29.7M
Total assets
$5.8B
$106.9M
Long term debt
$2.3B
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
